Health Care & Life Sciences » Pharmaceuticals | Whanin Pharmaceutical Co. Ltd.

Whanin Pharmaceutical Co. Ltd.

Whanin Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW1535.05
Market Cap
KRW266.41 B
Shares Outstanding
18.6 M
Public Float
11.32 M

Profile

Address
Whanin Building
Seoul SL 05809
Korea, Republic Of
Employees -
Website http://www.whanin.com
Updated 07/08/2019
Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. Its products include psychotropic agent, medicine for circulating system and digestive ulcers, therapeutic for osteoporosis, pain killers, and others. The company was founded by Lee Kwang-Sik in June 1978 is headquartered in Seoul, South Korea.

Financials

View All
Created with Highcharts 5.0.14Whanin Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.14 58014 58018 80618 80620 51020 51016 39716 39727 17227 17221 51821 51820132014201520162017201805k10k15k20k25k30k
Created with Highcharts 5.0.14Whanin Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.104 480104 480120 713120 713145 397145 397141 376141 376147 953147 953154 664154 664201320142015201620172018050k100k150k200k

Kwang-Sik Lee
Chairman & Co-Chief Executive Officer
Won-Bum Lee
President, Co-Chief Executive Officer & Director